A detailed history of Capital International LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital International LTD holds 59,728 shares of BMY stock, worth $3.45 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
59,728
Holding current value
$3.45 Million
% of portfolio
0.14%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $2.37 Million - $3.09 Million
59,728 New
59,728 $3.09 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $263,266 - $298,492
-5,487 Reduced 2.64%
202,304 $11 Million
Q4 2023

Feb 13, 2024

SELL
$48.48 - $57.85 $259,464 - $309,613
-5,352 Reduced 2.51%
207,791 $10.7 Million
Q3 2023

Nov 13, 2023

BUY
$57.89 - $64.73 $425,433 - $475,700
7,349 Added 3.57%
213,143 $12.4 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $2.25 Million - $2.5 Million
35,272 Added 20.68%
205,794 $13.2 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $2.12 Million - $2.4 Million
32,222 Added 23.3%
170,522 $11.8 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $395,951 - $468,862
5,782 Added 4.36%
138,300 $9.95 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $7,971 - $4.71 Million
61,316 Added 86.12%
132,518 $9.42 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $1.27 Million - $1.4 Million
17,443 Added 32.45%
71,202 $5.48 Million
Q1 2022

May 16, 2022

BUY
$61.48 - $73.72 $3.31 Million - $3.96 Million
53,759 New
53,759 $3.93 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Capital International LTD Portfolio

Follow Capital International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.